Inactive Instrument

Adorbs Inc.

ADOB

US00726D1046

Soul Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023

May 15, 2023 at 12:51 pm EDT

Soul Biotechnology Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.075413 million compared to USD 0.064731 million a year ago. Net loss was USD 0.060305 million compared to USD 0.03412 million a year ago.

Latest news about Adorbs Inc.

Adorbs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Soul Biotechnology Corporation has Changed its Name to Adorbs Inc	23-10-27	CI
Soul Biotechnology Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-27	CI
Adorbs Inc. has withdrawn its IPO in the amount of $4 million.	23-08-11	CI
Adorbs Inc. has filed an IPO in the amount of $4 million.	23-08-07	CI
Soul Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Soul Biotechnology Corporation Auditor Raises 'Going Concern' Doubt	23-03-12	CI
Adorbs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-21	CI
Adorbs Inc. Auditor Raises 'Going Concern' Doubt	22-02-09	CI

Chart Adorbs Inc.

Duration

Period

More charts

Company Profile

Adorbs Inc. is a developmental stage company. The Company is engaged in creation and commercialization of children's clothing with organic materials. The Company offers children's clothes such as leggings, t-shirt, sweatshirts, skirts, dresses, and onesies. The Company's clothing has basic bold colors, such as black, red, orange, yellow, green, grey, blue, purple, and fuchsia. It includes a variety of ideas with patch work, applique, food, emojis, animals, letters, and words. The Company sells products through its Website and buyer can choose size with a scroll bar, and choose the applique design.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+37.78%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	332B
ABBVIE INC.	+5.14%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals